Drug class
Selective serotonin 5-HT1F receptor agonist; ditan class acute migraine medicine
Mechanism of action
Binds 5-HT1F receptors in the trigeminal system and inhibits release of neuropeptides and nociceptive signalling associated with migraine. It does not produce the 5-HT1B-mediated vasoconstriction associated with triptans.
General use cases
- Acute treatment of migraine with or without aura in adults; not indicated for preventive treatment of migraine
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
